Please Note
We brought you to this page based on your search query. If this isn't what you are looking for, you can continue to Search Results for ""
The maximum number of items you can export is 3,000. Please reduce your list by using the filtering tool to the left.
Close
您即將離開穆迪台灣的地區網站,並會轉至穆迪全球網站(英文)。應否繼續?
不要再顯示此訊息

有關資料

主要連絡人

即將舉行的活動

有關產品

保健

重點

研究
機構
請進行精確搜尋以 市場 以獲得有關 評等活動觀察名單
  日期文件類型 主題 公司 / 組織
01 Mar 2024 Second Party Opinion Royal Philips N.V.: Second Party Opinion – Sustainable Financing Framework Assigned SQS2 (Use of Proceeds) and SQS2 (Sustainability-Linked) Royal Philips N.V.
08 Jan 2024 Outlook ESG - Global: 2024 Outlook – Green tech, policy and climate finance to drive credit impact
 The document has been translated in other languages

28 Sep 2023 Rating Methodology-Cross Sectr General Principles for Assessing Environmental, Social and Governance Risks methodology
 The document has been translated in other languages

28 Sep 2023 Methodology Supplement General Principles for Assessing Environmental, Social and Governance Risks Methodology Appendix H — Carbon Transition Indicators
 The document has been translated in other languages

17 Aug 2023 Sector In-Depth Demographics – China: Aging population, smaller workforce will have broad implications across sectors
 The document has been translated in other languages

07 Aug 2023 Sector In-Depth Medical Products and Devices – Japan: Financial buffers reflect capacity to grow via acquisitions amid population aging
 The document has been translated in other languages

07 Jun 2023 Sector Comment Commercial Sterilization – US: Large companies can absorb increased costs to comply with EPA emissions-cut proposal
25 Jul 2022 Sector In-Depth Healthcare Services – US and Europe: ESG considerations have moderately negative credit impact on most companies
17 Feb 2022 Sector In-Depth Pharmaceuticals and Healthcare – Europe: Developments to watch in 2022: COVID-19, M&A, inflation and regulation
01 Jun 2021 Sector In-Depth Medical Products and Devices – Global: ESG considerations have a negative to neutral credit impact on the sector
Complete Your Profile
Please complete your profile before submitting your comments.
We're Sorry